How Does Lomustine Work? Mechanism of Action Explained in Plain English

Lomustine (Gleostine) is one of the most effective oral chemotherapy agents for brain tumors, and its ability to work comes down to some fascinating chemistry. Understanding how lomustine works — in plain English — can help patients feel more informed about their treatment and understand why it has such a specific toxicity profile.

What Kind of Drug Is Lomustine?

Lomustine belongs to two related categories:

Alkylating agent: A type of chemotherapy that attaches chemical groups (alkyl groups) to DNA, preventing cancer cells from replicating

Nitrosourea: A subclass of alkylating agents that contain a nitrosourea chemical group, giving them the special property of crossing the blood-brain barrier

The Blood-Brain Barrier: Why It Matters

The blood-brain barrier (BBB) is a protective layer of cells lining the blood vessels in the brain. It filters what enters the brain from the bloodstream. This is great for protecting the brain from toxins and pathogens — but it also blocks most chemotherapy drugs from reaching brain tumors.

Lomustine is an exception. It is highly lipid-soluble (fat-soluble) and exists in an essentially non-ionized form at body pH. These two properties allow it to dissolve into and pass through the fatty membranes of the BBB. This is what makes lomustine one of the most valuable chemotherapy drugs for primary brain tumors.

How Lomustine Kills Cancer Cells: DNA Alkylation

Once lomustine enters cells (both cancer cells and some normal cells), it undergoes chemical reactions to become reactive. These reactive metabolites:

Alkylate DNA: Attach alkyl groups to specific sites on DNA strands (particularly the O6 position of guanine). This chemically modifies the DNA sequence.

Cross-link DNA strands: Create abnormal bonds between DNA strands that prevent the DNA from being correctly unwound and copied during cell division.

Alkylate RNA: Interfere with RNA, disrupting protein synthesis.

Carbamoylate proteins: Inhibit key enzymes required for DNA repair and cell function by chemically modifying amino acids in proteins.

The result: the cancer cell cannot divide properly or repair itself, leading to programmed cell death (apoptosis).

Why Is It Cell-Cycle Non-Specific?

Many chemotherapy drugs only kill cells that are actively dividing in a specific phase of the cell cycle. Lomustine is cell-cycle phase-nonspecific — it damages DNA in cancer cells regardless of where those cells are in the division cycle. This is an advantage because tumors contain both actively dividing cells and quiescent cells; lomustine can affect both populations.

MGMT: Why Some Tumors Respond Better

A key enzyme called MGMT (O6-methylguanine-DNA methyltransferase) repairs the type of DNA damage that alkylating agents like lomustine cause. Tumor cells with the MGMT gene promoter methylated (silenced) cannot produce this repair enzyme — making them much more sensitive to lomustine and other alkylating agents. Oncologists test for MGMT methylation status in glioblastoma patients to help predict how well alkylating chemotherapy will work.

Why Does Lomustine Suppress Bone Marrow?

Lomustine's mechanism does not discriminate between cancer cells and healthy, fast-dividing cells. Bone marrow cells — which produce blood cells — are among the fastest dividing cells in the body. Lomustine damages these cells too, which is why it causes the dangerous delayed myelosuppression (bone marrow suppression) that appears 28–42 days after each dose.

Cross-Resistance With Carmustine

Carmustine (BCNU) and lomustine (CCNU) share the same mechanism of action and cross-resistance has been documented. This means that if a tumor has developed resistance to lomustine, it is likely also resistant to carmustine — an important consideration when sequencing treatments.

Want to learn more about lomustine? Read What Is Lomustine? for a complete overview. If you need help finding lomustine at a pharmacy, medfinder can help locate it near you.